NCT00003359View on ClinicalTrials.gov

T138067 Sodium in Treating Patients With Advanced Refractory Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 1998

Primary Completion Date

January 31, 2001

Study Completion Date

January 31, 2001

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

batabulin sodium

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003359 - T138067 Sodium in Treating Patients With Advanced Refractory Cancer | Biotech Hunter | Biotech Hunter